Interferon Panel Results Interpretation Guide

Pathway Analysis

The following sections summarize key components of interferon-mediated immune signaling suggested by the measured analytes. Interferons are critical regulators of antiviral defense and immune coordination, with distinct functional roles across type I, type II, and type III pathways.

These pathway-level interpretations reflect activation of interferon responses and their downstream effects, including immune cell recruitment. Results should be interpreted in the context of clinical findings and other laboratory data.

Type I Interferon–Associated Antiviral Signaling

Back to top

Type I interferons are central to the innate immune response against viral infections. They are rapidly produced following detection of viral nucleic acids and initiate broad antiviral programs by inducing interferon-stimulated genes (ISGs), enhancing antigen presentation, and activating innate and adaptive immune cells.

Core Type I Interferons

  • IFNα2 – A key antiviral cytokine produced primarily by plasmacytoid dendritic cells, driving systemic antiviral responses.
  • IFNβ – Produced by many cell types following viral sensing; plays a central role in early antiviral defense and immune activation.
  • IFNω – A less abundant type I interferon with similar antiviral and immunomodulatory functions.

Supporting Context

  1. Paul F, Pellegrini S, Uzé G. IFNA2: The prototypic human alpha interferon. Gene. Aug 2015;567(2):132-7. doi:10.1016/j.gene.2015.04.087
  2. Wittling MC, Cahalan SR, Levenson EA, Rabin RL. Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes. Front Immunol. 2020;11:605673. doi:10.3389/fimmu.2020.605673
  3. de Weerd NA, Nguyen T. The interferons and their receptors–distribution and regulation. Immunol Cell Biol. May 2012;90(5):483-91. doi:10.1038/icb.2012.9
  4. Li SF, Zhao FR, Shao JJ, Xie YL, Chang HY, Zhang YG. Interferon-omega: Current status in clinical applications. Int Immunopharmacol. Nov 2017;52:253-260. doi:10.1016/j.intimp.2017.08.028

Type II Interferon (Th1-Associated) Immune Signaling

Back to top

Type II interferon signaling reflects activation of cell-mediated immunity and is closely associated with Th1 responses. It plays a critical role in macrophage activation, intracellular pathogen defense, and coordination of adaptive immune responses.

Core Type II Interferon

  • IFNγ – The principal type II interferon produced by Th1 cells, NK cells, and cytotoxic T cells. It drives macrophage activation, enhances antigen presentation, and orchestrates cellular immune responses1.

Supporting Context

  1. Ivashkiv LB. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 09 2018;18(9):545-558. doi:10.1038/s41577-018-0029-z

Type III Interferon–Associated Mucosal Antiviral Signaling

Back to top

Type III interferons provide antiviral protection primarily at epithelial and barrier surfaces, including the respiratory and gastrointestinal tracts. Their activity is more localized compared to type I interferons, helping to limit systemic inflammation while maintaining effective antiviral defense.

Core Type III Interferons

  • IFNλ1 (IL-29) – Promotes antiviral responses in epithelial tissues with limited systemic immune activation1.
  • IFNλ2 (IL-28A) – Functions similarly to IFNλ1 in supporting mucosal antiviral defense2.

Supporting Context

  1. Kelm NE, Zhu Z, Ding VA, et al. The role of IL-29 in immunity and cancer. Crit Rev Oncol Hematol. Oct 2016;106:91-8. doi:10.1016/j.critrevonc.2016.08.002
  2. Donnelly RP, Kotenko SV. Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res. Aug 2010;30(8):555-64. doi:10.1089/jir.2010.0078

Canonical Interferon-Responsive Chemokine Signaling

Back to top

This pathway reflects downstream effects of interferon activation, particularly the recruitment of immune cells to sites of infection or inflammation. These chemokines are strongly induced by interferon signaling and serve as markers of interferon pathway activity.

Core Interferon-Inducible Chemokines1,2

  • IP-10 (CXCL10) – Attracts activated T cells, NK cells, and monocytes; a widely used marker of interferon activity.
  • I-TAC (CXCL11) – Promotes migration of activated T cells and contributes to immune cell trafficking.
  • MIG (CXCL9) – Recruits Th1 cells and other CXCR3-expressing immune cells to sites of inflammation.

Supporting Context

  1. Liu M, Guo S, Hibbert JM, et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. Jun 2011;22(3):121-30. doi:10.1016/j.cytogfr.2011.06.001
  2. Metzemaekers M, Vanheule V, Janssens R, Struyf S, Proost P. Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands. Front Immunol. 2017;8:1970. doi:10.3389/fimmu.2017.01970